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me existence of tnarked elevations of ascitic fluid cholesterol has been observed in patients with peritoneal carcinomatosis 
compared to patients with cirrhosis and has been found useful in differential diagnosis. This finding could be caused by an 
enhanced movement of plasma lipoproteins into the peritoneal cavity. To test this hypothesis we determined the fasting 
concentrations of total, high density lipoprotein (HDL)- and low density lipoprotein (LDL)-cholesterol, apolipoprotein- 
A, (apo-Ai) and apolipoproteinB (apo-B) in serum and ascites of 17 patients with cirrhosis and 16 patients with peritoneal 
carcinomatosis. The movement of proteins from plasma to ascites was calculated from the ascitesiserum concentration ra- 
tios of six different sized proteins with a molecular mass ranging from 54 kDa to 971 kDa. Mean values (mg/dl) for total 
cholesterol (92.6 vs. 21.0), HDL-cholesterol (15.6 vs. 1.8), LDL-cholesterol (63.4 vs. l&l), apo-A, (50.2 vs. 13.6) and 
apo-B (41.2 vs. 12.9) in ascites were significantly higher in peritoneal carcinomatosis than in cirrhosis. These differences 
could only partially be explained by the higher serum concentrations of these parameters in peritoneal carcinomatosis, but 
were mainly due to a lower selectivity for the movement of plasma proteins and lipoproteins into ascites (mean ascites/se- 
rum (A/S) ratio: 0.30-0.77) in perisoneal carcInomatosis as compared to cirrhosis (mean ascites/serum ratio: 0.1.1-0.21). 
In both groups about 85% of the total cholesterol in serum and ascites consisted of HDL- and LDL-cholesterol. These find- 
ings support the hypothesis that elevations in ascitic cholesterol in peritoneal carcinomatosis compared to cirrhosis are 
mainly caused by the increased movement of plasma HDL and LDL into the peritoneal cavity. 
High total lipid concentrations have been reported in 
the ascites of patients with malignant neoplasms com- 
pared to patients with non-malignant ascites (1). In an ad- 
ditional study, markedly elevated concentrations of total 
cholesterol were found in malignant and inflammatory as- 
citic fluid compared to ascites from patients with cirrhosis 
(2). Recently these findings have been confirmed and the 
clinical value of ascitic cholesterol to differentiate be- 
tween cirrhotic and malignant ascites has been estab- 
lished (3-7). The pathogenesis of high ascitic cholesterol 
levels in patients with malignant disease is not fully under- 
stood. It has been suggested that a minor fraction of the 
cholesterol in malignant ascites might be derived from cell 
membranes and thus contribute to elevated ascitic con- 
centrations in these patients (8). Since low density Iipo- 
proteins have been isolated from ascitic fluid (8,9), the 
marked elevations of ascitic cholesterol observed in pa- 
tients with peritoneal carcinomatosis compared to pa- 
tients with cirrhosis could be caused by an enhanced 
movement of plasma lipoproteins into the peritoneal cavi- 
ty. To test this hypothesis, we compared the ascites to the 
serum relation of proteins and lipoproteins in patients 
with cirrhosis or peritoneal carcinomatosis. 
Materials and Methods 
Patients 
A total of 33 patients with ascites were investigated 
(mean age: 57; range: 15-81). The group with chronic 
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ASCITES TO SERUM RELAI’ION OF LIPOPROTEINS 
liver disease (I3 males and four females) included IO pa- 
tients with alcoholic arid seven patients with-posthepatitic 
cirrhosis. Since no differences of ascitic proteins and lipo- 
proteins between the two subgroups were observed they 
were considered one group for statistical evaEuarIor?. Six- 
teen patients suffered from peritoneal carcinomatosis 
(five males and 11 females): six with ovarian carcinoma, 
two with breast cancer, two with adenocarcinoma of the 
stomach and one each with leukemia, lymphoma, hepato- 
cellular carcinoma, carcinoma of bladder, carcinoma of 
kidney and adenocarcinoma of unknown or&is. Diagno- 
sis in all patients with cirrhosis was confirmed by biopsy, 
and hepatic malignancy was excluded by ultrasound or 
computed tomography. Twelve patients with peritoneal 
carcinomatosis had a positive ascitic cytology, and in four, 
the definitive diagnosis was made at autopsy. 
None of the patients with peritoneal carcinomatosis 
had laboratory or ultrasound evidence of liver metastasis. 
The length of the history of ascites in our patients 
varied from a few weeks to 2 years. Usually ascites in pa- 
tients with peritoneal carcinomatosis had been diagnosed 
only 2-6 weeks prior to admission to the hospital. Pa- 
tients with long-standing ascites mostly had liver disease 
due to the more favorable prognosis. The amount of ascit- 
ic fluid was classified by ultrasound and clinical examina- 
tion. Of 17 patients with cirrhosis seven revealed moder- 
ate and 10 tense ascites, and of 16 patients with peritoneal 
carcinomatosis ascites was moderate in nine and tense in 
seven cases. Fifteen of the 17 ascitic patients with cirrho- 
sis and 11 of the 16 patients with peritoneal carcinomato- 
sis received iuretic treatment at ihe time of the study. 
Collection ofspecimens 
In each patient, samples of blood and ascites were col- 
lected simultaneously after an overnight fast and centri- 
fuged at 3000 rpm for 10 min. The supematants were 
stored in 1 .O ml aliquots at -70 “C until analysis. 
Lipid assays 
Total cholesterol determination was performed enzy- 
matically with a commercial test kit (Boehringer, Mann- 
heim, F.R.G.) (10). HDL-cholesterol was determined af- 
ter precipitation of LDL and very low density lipoprotein 
(VLDL) with phosphotungstate and M$’ (11) and LDL- 
cholesterol was measured after precipitation with polyvi- 
nyl sulfate (12). 
Protein analysis 
Total protein was measured by a commercial biuret 
method (Merck, Darmstadt, F.R.G.) (13). The concen- 
trations of six proteins with different molecular masses, 
a,-antitrypsin (54 kDa), albumin (66 kDa), transferrin 
245 
), IgG (150 kDa), a,-macroglobulin (725 kDa) 
were determined 
specific antisera (Behring. 
d&ion, ape-A, and apo-B were measured by 
lometry as marker proteins for I-IDL and 
LDL, respectively (15). 
Stathical evaluation 
The results were analysed separately for the group with 
cirrhosis (17 patients) and the group with peritoneal carci- 
nomatosis (16 patients). 
In every patient an ascites/serum concentration ratio 
(A/S) ~2.3 calculated for each of the six proteins. In both 
groups, the mean A/S ratio for each protein was plotted 
against he logarithm of its molecular weight according to 
enderson et al. (16). Then two regression lines were 
computed by the method of least squares. 
Using mean and standard error of the mean (SE.), sta- 
tistical analysis of the data was performed by applying the 
Student unpaired t-test and the Spearman correlation 
coefficient. A p value below 0.05 was considered signifi- 
cant. 
Table I summarizes the concentrations in serum and as- 
cites of total cholesterol, HDL-cholesterol, LDL-choles- 
terol, apo-A and apo-B, in both groups of patients. Pa- 
TABLE 1 
Concentrations of total, HDL-, LDL-cholesterol, apo-A,, apo-B 
(mean + S.E.) and percentage of HDL- and LDL-cholesterol of to- 
tal cholesterol in serum and ascites of 17 patients with cirrhosis and 
16 patients with peritoneal carcinomatosis 
Cirrhosis Peritoneal 
carcinomatosis 
Total cholesterol 
(mg/dl) 
HDL-cholesterol 
(mg/dl) 
LDL-cholesterol 
(mg/dI) 
Apolipoprotein A, 
(mg/dI) 
Apolipoprotein B 
(mg/dI) 
HDL- and LDL- 
cholesteroVtotaI 
cholesterol 
@) 
serum 
ascites 
serum 
ascites 
serum 
ascites 
serum 
ascites 
serum 
ascites 
serum 
ascites 
92.0 + 9.2 
21.0 f 4.3 
20.8 + 3.6 
1.8 k 0.4 
59.0 f 6.7 
16.1 + 3.5 
55.0 + 7.5 
13.6 + 2.8 
58.8 + 6.2 
12.9 + 2.5 
85.0 f 2.0 
86.0 k 3.0 
157.0 Ik 7.9 
92.6 f 6.8 
36.5 + 2.1 
15.6 f 1.3 
94.5 + 6.2 
63.4 + 5.7 
loo.9 + 3.7 
50.2 f 2.4 
114.0 + 6.1 
41.2 + 2.3 
84.0 + 4.0 
85.0 t 2.0 
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tients with peritoneal carcinomatosis revealed l.dfold 
higher (p c 0.001) total serum cholesterol values com- 
pared to the subjects with cirrhosis. A similar ratio was 
observed concerning the concentrations of serum HDL- 
and LDL-cholesterol as well cis apo-A and apo-B. Ascites 
concentrations of these parameters differed more 
markedly with 4.0-fold higher values (p < 0.001) in peri- 
toneal carcinomatosis than in cirrhosis. In both groups 
about 85% of the total cholesterol in serum and ascites 
consisted of HDL- and LDL-cholesterol (Table 1). 
Total protein content and the concentrations of six pro- 
teins with different molecular weights determined in se- 
rum and ascites are displayed in Table 2. Ascites/serum 
ratios of these proteins were plotted against he logarithm 
of their corresponding molecular weight (Fig. 1). 
A significant negative correlation between asciteske- 
rum ratios and the mean of the molecular weight of the 
various proteins ‘-#as obtained in both groups of patients. 
The mean A/S ratios of the six proteins were about 3- 
times higher in the patients with peritoneal carcinomato- 
sis (mean A/S ratios: 0.38-0.77) than in the group with 
cirrhosis (mean A/S ratios: 0.12-0.2). In the total of 33 
patients, a close correlation of HDL-cholesterol and apo- 
A1 (r = 0.89, p < 0.001) and LDL-cholesterol and apo-B 
(r = 0.86, p < 0.0001) in ascites was found. The correla- 
tion between HDL-cholesterol and apo-A, in cirrhotic as- 
cites (r = 0.90,p < 0.0001) was higher in comparison with 
malignant ascites 0. = 0.59, p < 0.02). LDL-cholesterol 
and apo-B levels correlated similar in cirrhotic ascites 
(r = 0.69, p < 0.005) and malignant ascites (r = 0.60, p c 
0.02). For each group the mean A/S ratio of apo-A, and 
HDL-cholesterol was plotted against the log& of HDL 
and the mean A/S ratio of apo-B and LDL-cholesterol 
TABLE 2 
Concentrations of total protein and six different proteins in serum 
and ascites (mean + S.E.) of 17 patients with liver cirrhosis and 16 
patients with peritoneal carcinomatosis 
Cirrhosis Peritoneal 
carcinomatosis 
Total protein 
(g/d0 
a,-Antitrypsin 
(mg/dl) 54 kDa 
Albumin 
(mg/dl) 66 kDa 
Transferrin 
(mg/dl) 76 kDa 
IsG 
(mg/dl) 150 kDa 
az-Macroglobulin 
(mg/dl) 725 kDa 
IfN 
(mg/dl) 971 kDa 
serum 
ascites 
serum 
ascites 
serum 
ascites 
serum 
ascites 
serum 
ascites 
serum 
ascites 
serum 
ascites 
6.4 f 0.3 
1.6 f. 0.3 
290 f 19 
92f 18 
2648 + 111 
738 f 129 
179 ?I 16 
53 + 14 
1857 i 232 
403 -I- 71 
146+6 
24 zk 3 
237 + 32 
36 + 6 
6.4 + 0.2 
4.2 AI 0.2 
467 f 35 
340 & 29 
2997 f 163 
2287 -c 145 
205 + 8 
146 f 10 
1184 r 127 
778 + 83 
140 + 11 
56+5 
98 zk 10 
44+5 
0.8 
2l 
+’ 
s 
0.6. 
l sterol 
0.5. 
:: 
‘Z 
f! 0.4. 
5 ._ 
3 0.3 z 
8 
/ 
apo-B W 
5 0.2 +0-o. 
ape-A, LDL-cholesterol 
0 
tn 0.O 
3 
2 0.1 9 .+_Q 
HDL-cholesterol 
L 
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I 
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Fig. 1. Regression equation of IogM, against he ascitesjserum (A/S) ratio (mean + SE.) of six proteins (a,-antitrypsin, albumin, transferfin, 
IgG, cl,-macroglobulin, IgM) in 17 patients with liver cirrhosis (0) (r = 0.99, p c 0.0001) and of 16 patients with peritoneal carcinomatosis 
(0) (r = 0.96, p < 0.02). Mean f S.E. A/S ratios of apo-A, and HDL-cholesterol were plotted according to the lo@, of HDL and mean + SE. 
A/S ratios of apo-B and LDL-cholesterol were plotted in relation to the IogM, of LDL. 
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was plotted in relation to the log&f, of L 
These ratios fit reasonably in the 
which were calculated from the A/S ratios of the six pro- 
teins with different molecular weights. Tbe A/S ratios 
variations of all parameters were similar in t 
patients with liver cirrhosis and in the patients with perito- 
neal carcinomatosis. 
isesssion 
It has been demonstrated that ascites cholesterol con- 
centrations are markedly elevated in peritoneal carcino- 
matosis compared to cirrhosis and ascites cholesterol has 
been established as a parameter useful for the differential 
diagnosis of ascites (3-7). In an attempt to explain the 
elevated cholesterol concentration in malignant ascites, 
we compared the ascites to serum relation of proteins and 
lipoproteins in patients with cirrhosis or peritoneal carci- 
nomatosis. Most ascitic fluid samples from cirrhotic pa- 
tients were transudates with a protein concentration be- 
low 2.5 g/dl. 
The analysis of six different proteins with molecular 
masses from 54 kDa (cc,-antitrypsin) to 971 kDa (IgM) in 
cerum and ascites revealed a mean A/S ratio from 0.12 to 
0.2, which was significantly lower than in patients with 
peritoneal carcinomatosis (mean A/S ratio: 0.38-0.77). 
These findings demonstrate a higher selectivity in the 
movement of proteins from plasma to ascites in patients 
with cirrhosis than in patients with peritoneal carcinoma- 
tosis. Abnormalities in transcapillary-lymph hydrody- 
namics were a prominent feature in patients with cirrhosis 
and portal hypertension (17). Previous studies of the pro- 
tein content of central lymph, ascitic fluid, and intra-ab- 
dominal regional lymph indicate that both the digestive 
tract and the liver contribute to excess visceral lymph and 
peritoneal fluid (18). A whole spectrum of pre-sinusoidal 
and post-sinusoidal obstruction may exist with cirrhosis, 
and the protein content of thoracic duct lymph and ascitic 
fluid appears to reflect the spectrum. The increased portal 
pressure in patients with cirrhosis is counterbalanced by 
serum/ascites protein gradient (19) and the protein con- 
centration in ascites of patients with cirrhosis seems in- 
versely related to the degree of the portal pressure (20). 
Since there is a close correlation between total ascitic pro- 
tein and total cholesterol, one can assume that ascitic cho- 
lesterol as well as lipoprotein concentrations are inversely 
correlated to the height of the portal pressure (3). In- 
creased filtration seemed to be the dominant process of 
the elevated microvascular protein escape in cirrhosis due 
to increased hepatic and extrahepatic splanchnic transca- 
pillary protein flux (21). In our study, variations of total 
ascitic protein and of the AJS ratios of the different pro- 
teins in the group of patients with cirrhosis may reflect dif- 
ferences of portal pressure and pre- and post-sinusoidal 
obstruction (20). In patients with peritoneal carcinomato- 
S~S we obtained similar variations in the ascites/serum ra- 
tios of the six proteins. Increased endothelial permeabili- 
ty has been suggested as the major factor in the formation 
of ascites due to peritoneal carcinomatosis (22,23). Our 
results support this concept since all patients with perito- 
neal carcinomatosis howed exudative type of ascites with 
low selectivity for plasma proteins of different molecular 
weights. 
Lipoprotein (HDL and LDL) concentrations in serum, 
as well as in ascites, were significantly higher in patients 
with malignant neoplasms than in patients with cirrhosis. 
The differences of serum concentrations were most likely 
due to impaired hepatic lipoprotein synthesis in patients 
with cirrhosis. In serum and ascites of both groups about 
85% of the total cholesterol was recovered in the HDL ol‘ 
LDL fractions. These findings are in accordance with a 
previous study using gel filtration for fractionation of lipo- 
proteins in malignant ascites (8). Therefore, the marked 
differences between total, HDL- and LDL-cholesterol in 
ascitic samples from patients with cirrhosis and those with 
peritoneal cartiinomatosis could be explained only partial- 
ly by differences in serum concentrations. The main rea- 
son for about 4-fold higher concentrations of cholesterol 
in the ascites of patients with peritoneal carcinomatosis 
seems to be a lower selectivity for the movement of HDr_ 
and LDL from plasma to ascites. This assumption was 
supported by the characteristics of the A/S ratios of the six 
proteins and of apo-At, HDL-cholesterol, ape-B and 
LDL-cholesterol plotted in relation to the respective 
logM, (Fig. 1). These latter ratios fit reasonably well in 
the regression curves calculated from the A/S ratios of six 
proteins with varying molecular weights. 
It has been suggested that a decrease in ascites volume 
by diuretic treatment is associated with increased protein 
concentrations (24). In our study a similar ratio of patients 
in both groups received diuretic treatment. A consider- 
able decrease in ascites volume by diuretics is usually seen 
in cirrhotic patients, while patients with ascites and peri- 
toneal carcinomatosis remain refractory to diuretics in 
most cases. Thus, a possible increase of ascitic fluid pro- 
tein following diuretics would primarily affect the patients 
with cirrhosis and the actual difference in ascitic fluid pro- 
teins would be even greater. It has been suggested in a 
case report by Loiudice et al. that in cirrhotic patients 
with long-standing ascites there seemed to be a tendency 
for cholesterol concentrations to increase (25). The. histo- 
ry of ascites in our patients varied from a few weeks to 2 
years and tended to be longer in cirrhotic patients than in 
D. JONGST et al. 
those with peritoneal carcinomatosis. In particular, pa- 
tients with long-standing ascites w re generally cirrhotics. 
Furthermore, in serial studies of some ascitic patients, 
protein or lipid concentrations in the ascites did not in- 
crease during follow-up. Therefore, our results do not 
support he observation (25) that ascitic holesterol con- 
centration iscorrelated to the length of history of ascites. 
Lymphatic ongestion or blockage might have affected 
protein or lipoprotein concentrations in our patients with 
peritoneal carcinomatosis. However, liver metastasis had 
been excluded in these patients by abdominal ultrasound 
and no patient with chylous ascites was included in the 
study. Therefore, it seems unlikely that involvement of 
lymphatics might have affected our results. 
In conclusion, our results show thJ an increased move- 
ment of the plasma lipoproteins HDL and LDL into as- 
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